← Leaderboards
Howard Eliot Gendelman
Children'S Memorial Hospital (Chicago)
$44,946,535
Attributed
$58,928,263
Total exposure
31
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$87,496,813 · 33
By mechanism
R01$40,344,503 · 10
P01$38,461,759 · 14
R37$2,684,840 · 1
T32$2,100,260 · 2
P30$1,931,973 · 2
R61$1,228,661 · 1
Top collaborators
- Benson Edagwa14 shared
- Daniel T Monaghan9 shared
- R Lee Mosley8 shared
- Prasanta Kumar Dash5 shared
- Santhi Gorantla5 shared
- Larisa Y Poluektova5 shared
- Bhavesh Kevadiya2 shared
- Allison Michelle Andrews1 shared
Most similar at Children'S Memorial Hospital (Chicago)
Same institution · by research overlap
- Harris A Gelbard$27,114,187
Others in their field
Top investigators on “Macrophage”
- Craig B Thompson · Sloan-Kettering Inst Can Research$41,669,179
- Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
- Alan A Aderem · University Of Washington$38,969,733
- Alan Richard Tall · Columbia University Health Sciences$38,053,695
- John S Condeelis · Yeshiva University$33,855,255
- Christopher K Glass · University Of California, San Diego$31,538,574
Research focus
MacrophageCellsViralAnti-Retroviral AgentsPharmaceutical PreparationsMonocyteAntiretroviral TherapyTissuesBrainVirusAnimalsBaseVirus DiseasesResponseAffectLaboratoriesHiv-1Drug KineticsRodentLeadInfectionLinkNeuraxisImmune
Grant awards (186)
Dose flexible ultra-long-acting prodrug formulations for pediatric populations$1,228,661
R61 · FY2025 · AI
Prodrug Formulations Create Sustained-Release Antiretrovirals$744,473
R01 · FY2025 · AI
Targeted lipid nanoparticles for gene therapeutics delivery approach to eradicating HIV reservoirs$736,036
R01 · FY2025 · MH · contact PI
LASER ART for PreP$698,744
R01 · FY2025 · AI · contact PI
HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes$690,750
R01 · FY2025 · NS
Neuroprotective Immunity and HIV Dementia$690,748
R01 · FY2025 · NS · contact PI
Neuroimmunology of Disease Training Program$215,594
T32 · FY2025 · NS
29th-31st Scientific Conference Society on NeuroImmune Pharmacology$1
R13 · FY2025 · DA
Neuroprotective Immunity and HIV Dementia$767,498
R01 · FY2024 · NS · contact PI
LASER ART for PreP$698,744
R01 · FY2024 · AI · contact PI
HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes$690,750
R01 · FY2024 · NS
Neuroimmunology of Disease Training Program$60,566
T32 · FY2024 · NS
Neuroprotective Immunity and HIV Dementia$767,498
R01 · FY2023 · NS · contact PI
Prodrug Formulations Create Sustained Release Antiretrovirals$757,138
R01 · FY2023 · AI
LASER ART for PreP$698,743
R01 · FY2023 · AI · contact PI
HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes$690,750
R01 · FY2023 · NS
HIV Theranostic$683,816
R01 · FY2023 · MH · contact PI
Neuroimmunology of Disease Training Program$213,872
T32 · FY2023 · NS
Neuroimmunology of Disease Training Program$1,836
T32 · FY2023 · NS
Prodrug Formulations Create Sustained Release Antiretrovirals$757,138
R01 · FY2022 · AI
LASER ART for PreP$698,307
R01 · FY2022 · AI · contact PI
HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes$690,750
R01 · FY2022 · NS
HIV Theranostic$684,563
R01 · FY2022 · MH · contact PI
Neuroprotective Immunity and HIV Dementia$563,091
R01 · FY2022 · NS · contact PI
Neuroimmunology of Disease Training Program$85,531
T32 · FY2022 · NS · contact PI
Prodrug Formulations Create Sustained Release Antiretrovirals$757,138
R01 · FY2021 · AI
LASER ART for PreP$710,244
R01 · FY2021 · AI · contact PI
HIV-1 Detection and Elimination From CNS Mononuclear Phagocytes$688,500
R01 · FY2021 · NS
HIV Theranostic$685,287
R01 · FY2021 · MH · contact PI
Combined Molecular Excision Therapy (CMET) for Eliminating HIV-1$676,262
R01 · FY2021 · MH · contact PI
Neuroprotective Immunity and HIV Dementia$563,091
R01 · FY2021 · NS · contact PI
Therapeutics Core$203,176
P30 · FY2021 · MH · contact PI
Neuroimmunology of Disease Training Program$189,948
T32 · FY2021 · NS · contact PI
Prodrug Formulations Create Sustained Release Antiretrovirals$747,921
R01 · FY2020 · AI
HIV Theranostic$685,990
R01 · FY2020 · MH · contact PI
Combined Molecular Excision Therapy (CMET) for Eliminating HIV-1$680,886
R01 · FY2020 · MH · contact PI
Neuroprotective Immunity and HIV Dementia$641,481
R01 · FY2020 · NS · contact PI
Glutaminase and its neurotoxic link to HAND$376,250
R01 · FY2020 · NS · contact PI
Therapeutics Core$203,175
P30 · FY2020 · MH · contact PI
Neuroimmunology of Disease Training Program$187,718
T32 · FY2020 · NS · contact PI
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence$1,768,353
P01 · FY2019 · DA · contact PI
Prodrug Formulations Create Sustained Release Antiretrovirals$747,921
R01 · FY2019 · AI
HIV Theranostic$737,946
R01 · FY2019 · MH · contact PI
Combined Molecular Excision Therapy (CMET) for Eliminating HIV-1$685,375
R01 · FY2019 · MH · contact PI
Neuroprotective Immunity and HIV Dementia$641,481
R01 · FY2019 · NS · contact PI
Nanoformulation Uptake, Release, Toxicology and Tissue Delivery$270,900
P01 · FY2019 · DA · contact PI
Administration$223,727
P01 · FY2019 · DA · contact PI
Therapeutics Core$203,176
P30 · FY2019 · MH · contact PI
Neuroimmunology of Disease Training Program$185,541
T32 · FY2019 · NS · contact PI
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence$1,768,353
P01 · FY2018 · DA · contact PI
Chemical, Nanomedicine and Autophagy Strategies to Create Sustained-Release Antiretroviral Products$719,816
R56 · FY2018 · AI · contact PI
Combined Molecular Excision Therapy (CMET) for Eliminating HIV-1$689,734
R01 · FY2018 · MH · contact PI
Neuroprotective Immunity and HIV Dementia$561,860
R01 · FY2018 · NS · contact PI
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence$305,000
P01 · FY2018 · DA · contact PI
Nanoformulation Uptake, Release, Toxicology and Tissue Delivery$285,950
P01 · FY2018 · DA · contact PI
Administration$214,461
P01 · FY2018 · DA · contact PI
Therapeutics Core$207,654
P30 · FY2018 · MH · contact PI
Neuroimmunology of Disease Training Program$183,416
T32 · FY2018 · NS · contact PI
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence$1,771,276
P01 · FY2017 · DA · contact PI
Combined Molecular Excision Therapy (CMET) for Eliminating HIV-1$781,703
R01 · FY2017 · MH · contact PI
Nanomedicine and NeuroAIDS$675,626
R01 · FY2017 · NS · contact PI
SMART HAND$625,779
R01 · FY2017 · AG · contact PI
Nanoformulation Uptake, Release, Toxicology and Tissue Delivery$285,950
P01 · FY2017 · DA · contact PI
Administration$214,462
P01 · FY2017 · DA · contact PI
Therapeutics Core$203,175
P30 · FY2017 · MH · contact PI
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence$1,744,391
P01 · FY2016 · DA · contact PI
Nanomedicine and NeuroAIDS$675,626
R01 · FY2016 · NS · contact PI
SMART HAND$625,779
R01 · FY2016 · AG · contact PI
Neuroprotective Immunity and HIV Dementia$371,250
R01 · FY2016 · NS · contact PI
Nanoformulation Uptake, Release, Toxicology and Tissue Delivery$283,090
P01 · FY2016 · DA · contact PI
Administration$212,318
P01 · FY2016 · DA · contact PI
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence$1,774,636
P01 · FY2015 · DA · contact PI
Nanomedicine and NeuroAIDS$675,626
R01 · FY2015 · NS · contact PI
SMART HAND$607,005
R01 · FY2015 · AG · contact PI
Neuroprotective Immunity and HIV Dementia$371,250
R01 · FY2015 · NS · contact PI
Nanoformulation Uptake, Release, Toxicology and Tissue Delivery$285,950
P01 · FY2015 · DA · contact PI
Administration$214,461
P01 · FY2015 · DA · contact PI
Therapeutics Core (Page 286)$174,391
P30 · FY2015 · MH · contact PI
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence$1,561,399
P01 · FY2014 · DA · contact PI
SMART HAND$625,779
R01 · FY2014 · AG · contact PI
Nanomedicine and NeuroAIDS$575,618
R01 · FY2014 · NS · contact PI
Neuroprotective Immunity and HIV Dementia$367,537
R01 · FY2014 · NS · contact PI
Therapeutics Core (Page 286)$176,883
P30 · FY2014 · MH · contact PI
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence$1,498,944
P01 · FY2013 · DA · contact PI
SMART HAND$625,779
R01 · FY2013 · AG · contact PI
Nanomedicine and NeuroAIDS$581,431
R01 · FY2013 · NS · contact PI
Neuroprotective Immunity and HIV Dementia$358,256
R01 · FY2013 · NS · contact PI
Therapeutics Core (Page 286)$174,095
P30 · FY2013 · MH · contact PI
Neuronanomedicine$25,000
R13 · FY2013 · NS · contact PI
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence$1,561,399
P01 · FY2012 · DA · contact PI
Neural Immunity in HIV Dementia$1,131,457
P01 · FY2012 · NS · contact PI
Nanomedicine and NeuroAIDS$457,076
R01 · FY2012 · NS · contact PI
Neuroprotective Immunity and HIV Dementia$371,250
R01 · FY2012 · NS · contact PI
Nanoformulation Uptake, Release, Toxicology and Tissue Delivery$313,975
P01 · FY2012 · DA · contact PI
Macrophage-based nanoformulations of anti-retroviral therapy in NeuroAIDS$214,978
P01 · FY2012 · NS · contact PI
Therapeutics Core (Page 286)$184,919
P30 · FY2012 · MH · contact PI
Administration$162,624
P01 · FY2012 · DA · contact PI
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence$145,530
P01 · FY2012 · DA · contact PI
Administrative Core$113,146
P01 · FY2012 · NS · contact PI
Therapeutics Core (Page 286)$11,249
P30 · FY2012 · MH · contact PI
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence$1,606,022
P01 · FY2011 · DA · contact PI
Neural Immunity in HIV Dementia$1,139,991
P01 · FY2011 · NS · contact PI
Nanomedicine and NeuroAIDS$452,334
R01 · FY2011 · NS · contact PI
Neuroprotective immunity and HIV dementia$360,150
R01 · FY2011 · NS · contact PI
Nanoformulation Uptake, Release, Toxicology and Tissue Delivery$297,150
P01 · FY2011 · DA · contact PI
Macrophage-based nanoformulations of anti-retroviral therapy in NeuroAIDS$216,598
P01 · FY2011 · NS · contact PI
Therapeutics Core (Page 286)$190,080
P30 · FY2011 · MH · contact PI
Administration$152,891
P01 · FY2011 · DA · contact PI
Administrative Core$114,003
P01 · FY2011 · NS · contact PI
NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence$1,263,938
P01 · FY2010 · DA · contact PI
Neural Immunity in HIV Dementia$1,164,241
P01 · FY2010 · NS · contact PI
Nanomedicine and NeuroAIDS$460,848
R01 · FY2010 · NS · contact PI
Neuroprotective immunity and HIV dementia$363,825
R01 · FY2010 · NS · contact PI
Nanoformulation Uptake, Release, Toxicology and Tissue Delivery$223,457
P01 · FY2010 · DA · contact PI
Macrophage-based nanoformulations of anti-retroviral therapy in NeuroAIDS$221,206
P01 · FY2010 · NS · contact PI
METH, HIV-1 and Glial Crosstalk$147,801
P01 · FY2010 · DA · contact PI
Administrative Core$116,424
P01 · FY2010 · NS · contact PI
Administration$114,214
P01 · FY2010 · DA · contact PI
Neuroprotective immunity and HIV dementia$37,125
R01 · FY2010 · NS · contact PI
Neural Immunity in HIV Dementia$1,176,000
P01 · FY2009 · NS · contact PI
Nanomedicine and NeuroAIDS$448,842
R01 · FY2009 · NS · contact PI
Neuroprotective immunity and HIV dementia$367,500
R01 · FY2009 · NS · contact PI
Macrophage-based nanoformulations of anti-retroviral therapy in NeuroAIDS$240,890
P01 · FY2009 · NS · contact PI
METH, HIV-1 and Glial Crosstalk$149,294
P01 · FY2009 · DA · contact PI
Administrative Core$126,785
P01 · FY2009 · NS · contact PI
Neural Immunity in HIV Dementia$91,840
P01 · FY2009 · NS · contact PI
Neural Immunity in HIV Dementia$1,176,000
P01 · FY2008 · NS · contact PI
Nanomedicine and NeuroAIDS$424,461
R01 · FY2008 · NS · contact PI
Neuroprotective immunity and HIV dementia$367,500
R01 · FY2008 · NS · contact PI
Macrophage-based nanoformulations of anti-retroviral therapy in NeuroAIDS$223,440
P01 · FY2008 · NS · contact PI
METH, HIV-1 and Glial Crosstalk$144,409
P01 · FY2008 · DA · contact PI
Administrative Core$117,600
P01 · FY2008 · NS · contact PI
Neuronal Immunity in HIV Dementia$1,137,512
P01 · FY2007 · NS · contact PI
Neuroprotective immunity and HIV dementia$367,500
R01 · FY2007 · NS · contact PI
Blood Brain Barrier Physiology and HIV Dementia$348,456
R37 · FY2007 · NS · contact PI
Pathways of Neuronal Damage Involving Macrophage-Glia Interactions In Vivo$221,620
P01 · FY2007 · NS · contact PI
Proteomics Core$189,586
P01 · FY2007 · NS · contact PI
Protective Immunity in HIV Dementia$189,585
P01 · FY2007 · NS · contact PI
Neuronal Immunity in HIV Dementia$1,171,485
P01 · FY2006 · NS · contact PI
Blood Brain Barrier Physiology and HIV Dementia$358,864
R37 · FY2006 · NS · contact PI
Molecular Mechanisms of HIV Neuropathogenesis$340,921
R01 · FY2006 · NS · contact PI
Pathways of Neuronal Damage Involving Macrophage-Glia Interactions In Vivo$225,083
P01 · FY2006 · NS · contact PI
Proteomics Core$199,945
P01 · FY2006 · NS · contact PI
Protective Immunity in HIV Dementia$199,945
P01 · FY2006 · NS · contact PI
Training Program in Neurovirology$147,909
T32 · FY2006 · NS · contact PI
Neuronal Immunity in HIV Dementia$1,202,916
P01 · FY2005 · NS
Blood Brain Barrier Physiology and HIV Dementia$367,500
R37 · FY2005 · NS
Molecular Mechanisms of HIV Neuropathogenesis$349,125
R01 · FY2005 · NS
Pathways of Neuronal Damage Involving Macrophage-Glia Interactions In Vivo$218,565
P01 · FY2005 · NS
Proteomics Core$200,485
P01 · FY2005 · NS
Protective Immunity in HIV Dementia$200,485
P01 · FY2005 · NS
Training Program in Neurovirology$173,158
T32 · FY2005 · NS
Neuronal Immunity in HIV Dementia$1,203,934
P01 · FY2004 · NS
Blood Brain Barrier Physiology and HIV Dementia$376,454
R37 · FY2004 · NS
Molecular Mechanisms of HIV Neuropathogenesis$349,125
R01 · FY2004 · NS
Pathways of Neuronal Damage Involving Macrophage-Glia Interactions In Vivo$212,497
P01 · FY2004 · NS
Proteomics Core$200,655
P01 · FY2004 · NS
Protective Immunity in HIV Dementia$200,655
P01 · FY2004 · NS
Training Program in Neurovirology$156,180
T32 · FY2004 · NS
Neuronal Immunity in HIV Dementia$1,203,933
P01 · FY2003 · NS
Blood Brain Barrier Physiology and HIV Dementia$367,500
R37 · FY2003 · NS
Molecular Mechanisms of HIV Neuropathogenesis$349,125
R01 · FY2003 · NS
Pathways of Neuronal Damage Involving Macrophage-Glia Interactions In Vivo$214,874
P01 · FY2003 · NS
Proteomics Core$200,655
P01 · FY2003 · NS
Protective Immunity in HIV Dementia$200,655
P01 · FY2003 · NS
Training Program in Neurovirology$162,466
T32 · FY2003 · NS
Blood Brain Barrier Physiology and HIV Dementia$8,710
R37 · FY2003 · NS
Blood Brain Barrier Physiology and HIV Dementia$376,731
R37 · FY2002 · NS
MOLECULAR MECHANISMS OF HIV NEUROPATHOGENESIS$366,705
R01 · FY2002 · NS
Core--cell, tissue and animal facility$266,631
P01 · FY2002 · MH
Core--cell, tissue and animal facility$266,631
P01 · FY2002 · MH
Training Program in Neurovirology$136,525
T32 · FY2002 · NS
Blood Brain Barrier Physiology and HIV Dementia$52,644
R37 · FY2002 · NS
Blood Brain Barrier Physiology and HIV Dementia$9,231
R37 · FY2002 · NS
MOLECULAR MECHANISMS OF HIV NEUROPATHOGENESIS$383,285
R01 · FY2001 · NS
Blood Brain Barrier Physiology and HIV Dementia$368,750
R37 · FY2001 · NS
NEURONAL ELECTROPHYSIOLOGY IN HIV DEMENTIA$259,393
R01 · FY2001 · NS
Blood Brain Barrier Physiology and HIV Dementia$50,000
R37 · FY2001 · NS
Core--cell, tissue and animal facility$0
P01 · FY2001 · MH
MOLECULAR MECHANISMS OF HIV NEUROPATHOGENESIS$394,830
R01 · FY2000 · NS
MACROPHAGE MEDIATED NEUROTOXICITY OF HIV 1 DEMENTIA$382,503
P01 · FY2000 · MH
HIV-1, MONOCYTES AND THE BLOOD/BRAIN BARRIER$237,042
R01 · FY2000 · NS
NEURONAL ELECTROPHYSIOLOGY IN HIV DEMENTIA$227,020
R01 · FY2000 · NS
MOLECULAR MECHANISMS OF HIV NEUROPATHOGENESIS$50,000
R01 · FY2000 · NS
NEURONAL ELECTROPHYSIOLOGY IN HIV DEMENTIA$18,900
R01 · FY2000 · NS
MOLECULAR MECHANISMS OF HIV NEUROPATHOGENESIS$9,673
R01 · FY2000 · NS